Pradhan_2022_J.Mol.Neurosci__

Reference

Title : Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease - Pradhan_2022_J.Mol.Neurosci__
Author(s) : Pradhan LK , Sahoo PK , Chauhan S , Das SK
Ref : Journal of Molecular Neuroscience , : , 2022
Abstract :

Since the report of "a peculiar severe disease process of the cerebral cortex" by Alois Alzheimer in 1906, it was considered to be a rare condition characterized by loss of cognition, memory impairment, and pathological markers such as senile plaques or neurofibrillary tangles (NFTs). Later on, the report was published in the textbook "Psychiatrie" and the disease was named as Alzheimer's disease (AD) and was known to be the consequences of aging; however, owing to its complex etiology, there is no cure for the progressive neurodegenerative disorder. Our current understanding of the mechanisms involved in the pathogenesis of AD is still at the mechanistic level. The treatment strategies applied currently only alleviate the symptoms and co-morbidities. For instance, the available treatments such as the usage of acetylcholinesterase inhibitors and N-methyl D-aspartate antagonists have minimal impact on the disease progression and target the later aspects of the disease. The recent advancements in the last two decades have made us more clearly understand the pathophysiology of the disease which has led to the development of novel therapeutic strategies. This review gives a brief idea about the various facets of AD pathophysiology and its management through modern investigational therapies to give a new direction for development of targeted therapeutic measures.

PubMedSearch : Pradhan_2022_J.Mol.Neurosci__
PubMedID: 35553375

Related information

Citations formats

Pradhan LK, Sahoo PK, Chauhan S, Das SK (2022)
Recent Advances Towards Diagnosis and Therapeutic Fingerprinting for Alzheimer's Disease
Journal of Molecular Neuroscience :

Pradhan LK, Sahoo PK, Chauhan S, Das SK (2022)
Journal of Molecular Neuroscience :